WINTON GROUP Ltd boosted its position in shares of HCA Healthcare Inc (NYSE:HCA) by 3,350.7% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 205,078 shares of the company’s stock after acquiring an additional 199,135 shares during the quarter. WINTON GROUP Ltd’s holdings in HCA Healthcare were worth $28,530,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. FMR LLC lifted its position in HCA Healthcare by 54.9% during the 2nd quarter. FMR LLC now owns 5,488,273 shares of the company’s stock worth $563,097,000 after acquiring an additional 1,944,961 shares during the period. Millennium Management LLC lifted its position in HCA Healthcare by 32.3% during the 2nd quarter. Millennium Management LLC now owns 1,698,536 shares of the company’s stock worth $174,270,000 after acquiring an additional 414,877 shares during the period. Highstreet Asset Management Inc. acquired a new stake in HCA Healthcare during the 2nd quarter worth about $707,000. Stephens Inc. AR acquired a new stake in HCA Healthcare during the 2nd quarter worth about $1,393,000. Finally, Tavio Capital LLC lifted its position in HCA Healthcare by 51.9% during the 2nd quarter. Tavio Capital LLC now owns 197,318 shares of the company’s stock worth $20,245,000 after acquiring an additional 67,385 shares during the period. 70.84% of the stock is owned by institutional investors.
HCA has been the subject of a number of research reports. Jefferies Financial Group lifted their price target on HCA Healthcare to $155.00 and gave the stock a “buy” rating in a research report on Friday, September 21st. Leerink Swann lifted their price target on HCA Healthcare from $140.00 to $150.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 4th. Mizuho set a $150.00 price target on HCA Healthcare and gave the stock a “buy” rating in a research report on Tuesday, September 4th. Argus lifted their price target on HCA Healthcare to $150.00 and gave the stock a “buy” rating in a research report on Friday, September 7th. Finally, Royal Bank of Canada lifted their price target on HCA Healthcare to $150.00 and gave the stock an “outperform” rating in a research report on Monday, September 10th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the stock. HCA Healthcare has a consensus rating of “Buy” and a consensus target price of $141.26.
In related news, SVP Deborah M. Reiner sold 723 shares of the company’s stock in a transaction dated Monday, November 5th. The stock was sold at an average price of $135.06, for a total value of $97,648.38. Following the completion of the transaction, the senior vice president now owns 6,184 shares of the company’s stock, valued at approximately $835,211.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Jane D. Englebright sold 6,543 shares of the company’s stock in a transaction dated Wednesday, August 15th. The stock was sold at an average price of $129.86, for a total value of $849,673.98. Following the completion of the transaction, the senior vice president now directly owns 7,443 shares of the company’s stock, valued at approximately $966,547.98. The disclosure for this sale can be found here. Insiders sold a total of 12,462 shares of company stock valued at $1,656,680 in the last ninety days. 2.80% of the stock is currently owned by insiders.
Shares of HCA stock opened at $135.53 on Tuesday. The stock has a market capitalization of $46.52 billion, a PE ratio of 20.57, a P/E/G ratio of 1.18 and a beta of 0.48. HCA Healthcare Inc has a 52-week low of $74.26 and a 52-week high of $141.11.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.93 by $0.23. The business had revenue of $11.45 billion during the quarter, compared to analysts’ expectations of $11.29 billion. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.13 EPS. Sell-side analysts expect that HCA Healthcare Inc will post 9.33 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be issued a $0.35 dividend. The ex-dividend date is Friday, November 30th. This represents a $1.40 dividend on an annualized basis and a yield of 1.03%. HCA Healthcare’s payout ratio is 21.24%.
TRADEMARK VIOLATION NOTICE: “WINTON GROUP Ltd Raises Holdings in HCA Healthcare Inc (HCA)” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/11/06/winton-group-ltd-raises-holdings-in-hca-healthcare-inc-hca.html.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: Understanding Price to Earnings Ratio (PE)
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.